Companhia Brasileira de Distribuição (NYSE: CBD) Stock Competitors & Peer Comparison
See CBD's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Department Stores Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for CBD and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CBD | $0.45 | -3.05% | 218.1M | -14.83 | -$0.03 | N/A |
| DDS | $585.08 | +0.93% | 9.1B | 14.96 | $39.09 | +5.36% |
| M | $23.24 | +0.06% | 6.1B | 10.10 | $2.30 | +3.23% |
| JWN | $24.66 | +0.08% | 4.1B | 14.17 | $1.74 | +3.08% |
| PLBL | $6.00 | -6.98% | 2.2B | -297.50 | -$0.02 | N/A |
| KSS | $18.70 | -3.03% | 2.1B | 11.69 | $1.60 | +2.61% |
| EXTO | $3.61 | -0.55% | 585.7M | 90.25 | $0.04 | +1.34% |
| DDT | $26.32 | +0.03% | 415.9M | 0.60 | $43.74 | +7.13% |
Stock Comparison
Dillard's, Inc. (NYSE: DDS)
CBD vs DDS Comparison August 2026
Companhia Brasileira de Distribuição (NYSE: CBD) plays a significant role within the Consumer Cyclical sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBD stands at 218.1M. In comparison, DDS has a market cap of 9.1B. Regarding current trading prices, CBD is priced at $0.45 on the NYSE, while DDS trades at $585.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBD currently has a P/E ratio of -14.83, whereas DDS's P/E ratio is 14.96. In terms of profitability, CBD's ROE is -0.14%, compared to DDS's ROE of +0.32%. Regarding short-term risk, CBD is more volatile compared to DDS. This indicates higher risk in terms of short-term price fluctuations for CBD.Check DDS's competition here